Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL USE OF CDK4/6 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2023/040914
Kind Code:
A1
Abstract:
Disclosed are a method for treating cancer with a CDK4/6 inhibitor and a corresponding pharmaceutical use. The CDK4/6 inhibitor is 5-fluoro-4-(7'-fluoro-2'-methylspiro[cyclopentane-1, 3'-indole]-5'-yl)-nitrogen-(5-(1-methylpiperidin-4-yl)pyridin-2-yl)pyrimidin-2-amine, and said cancer comprises colorectal cancer, liver cancer, or breast cancer. The CDK4/6 inhibitor has a good tumor suppression effect.

Inventors:
YIN LEI (CN)
YAO ZHENGLIN (CN)
Application Number:
PCT/CN2022/118817
Publication Date:
March 23, 2023
Filing Date:
September 14, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GAN & LEE PHARMACEUTICALS CO LTD (CN)
International Classes:
A61K31/506; A61P35/00; C07D401/14; C07D471/04
Foreign References:
CN106810536A2017-06-09
CN106608879A2017-05-03
CN102264725A2011-11-30
CN101001857A2007-07-18
Other References:
LEI YIN, HENG LI, WENJIAN LIU, ZHENGLIN YAO, ZHENZHEN CHENG, HUABEI ZHANG, HUI ZOU: "A highly potent CDK4/6 inhibitor was rationally designed to overcome blood brain barrier in gliobastoma therapy", EUROEPAN JOURNAL OF MEDICINAL CHEMISTRY, ELSEVIER, pages 1 - 28, XP055766971, [retrieved on 20210120]
Download PDF: